1. Home
  2. GO vs EVO Comparison

GO vs EVO Comparison

Compare GO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GO
  • EVO
  • Stock Information
  • Founded
  • GO 1946
  • EVO 1993
  • Country
  • GO United States
  • EVO Germany
  • Employees
  • GO N/A
  • EVO N/A
  • Industry
  • GO Food Chains
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GO Consumer Staples
  • EVO Health Care
  • Exchange
  • GO Nasdaq
  • EVO Nasdaq
  • Market Cap
  • GO 1.3B
  • EVO 1.4B
  • IPO Year
  • GO 2019
  • EVO 2021
  • Fundamental
  • Price
  • GO $12.15
  • EVO $3.05
  • Analyst Decision
  • GO Hold
  • EVO Strong Buy
  • Analyst Count
  • GO 13
  • EVO 1
  • Target Price
  • GO $16.62
  • EVO $7.00
  • AVG Volume (30 Days)
  • GO 3.0M
  • EVO 55.2K
  • Earning Date
  • GO 11-04-2025
  • EVO 11-05-2025
  • Dividend Yield
  • GO N/A
  • EVO N/A
  • EPS Growth
  • GO N/A
  • EVO N/A
  • EPS
  • GO N/A
  • EVO N/A
  • Revenue
  • GO $4,571,346,000.00
  • EVO $887,396,457.00
  • Revenue This Year
  • GO $11.29
  • EVO N/A
  • Revenue Next Year
  • GO $5.65
  • EVO $10.78
  • P/E Ratio
  • GO N/A
  • EVO N/A
  • Revenue Growth
  • GO 7.22
  • EVO N/A
  • 52 Week Low
  • GO $10.26
  • EVO $2.84
  • 52 Week High
  • GO $21.67
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • GO 27.07
  • EVO 23.49
  • Support Level
  • GO $11.55
  • EVO $3.30
  • Resistance Level
  • GO $14.49
  • EVO $4.09
  • Average True Range (ATR)
  • GO 0.71
  • EVO 0.10
  • MACD
  • GO -0.21
  • EVO -0.12
  • Stochastic Oscillator
  • GO 18.65
  • EVO 2.78

About GO Grocery Outlet Holding Corp.

Grocery Outlet Holding Corp is a grocery store operator in the United States. It is a retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: